Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Knee Osteoarthritis (AMAZE 6)
Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Knee Osteoarthritis (AMAZE 6)
This study is being done to look at the safety and effect of NNC0487-0111 in people with excess body weight and knee osteoarthritis when compared to placebo. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111, (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
Key Inclusion Criteria:
Key Exclusion Criteria:
clinicaltrials@novonordisk.com(+1) 866-867-7178
Chaïdári, Attica 12461, Greece
Athens, 115 27, Greece
Athens, 11525, Greece
Marousi, 15125, Greece
Thessaloniki, 54635, Greece
Udine, Friuli Venezia Giulia 33100, Italy
Milan, Lombardy 20149, Italy
Milan, Lombardy 20157, Italy
San Donato Milanese, Lombardy 20097, Italy
Verona, Veneto 37126, Italy
Bialystok, Podlaskie Voivodeship 15-351, Poland
Krakow, 31-826, Poland
Warsaw, 02-637, Poland
Bahçelievler/İstanbul, 34186, Turkey (Türkiye)
Çankaya/Ankara, 06800, Turkey (Türkiye)
Çankaya/Ankara, 06800, Turkey (Türkiye)
Edirne, 22030, Turkey (Türkiye)
Fatih/İstanbul, 34116, Turkey (Türkiye)
Yuregir/Adana, 01060, Turkey (Türkiye)
Yıldırım/Bursa, 16310, Turkey (Türkiye)